Association between anti-citrullinated fibrinogen antibodies and coronary artery disease in rheumatoid arthritis
Arthritis Care & Research Oct 16, 2017
Hejblum BP, et al. - The target of this trial was to contemplate the tie-up between anti-cit-fibrinogens and coronary artery disease (CAD) outcomes. The data revealed that anti-cit-fibrinogen antibodies as a group correlated with CAD outcomes in patients with rheumatoid arthritis (RA). The strongest signal for the connection arose from a subset of the autoantibodies.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
